Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record now indicates that the trial is no longer recruiting participants, and it adds the latest revision (v3.6.0) while removing the previous revision (v3.5.5) from the history.SummaryDifference0.2%

- Check18 days agoChange DetectedA new revision entry v3.5.5 was added to the history, and the previous entry v3.5.4 was removed from the visible list, reflecting an update to the record's revision history.SummaryDifference0.1%

- Check39 days agoChange DetectedThe history page now shows a new release note entry 'Revision: v3.5.4' replacing the previous 'Revision: v3.5.3', indicating a software update to the ClinicalTrials.gov interface rather than a change to the study record.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page header/footer shows an update to the interface version from v3.5.2 to v3.5.3, indicating a software/display release rather than a change to the trial record itself.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.